Voyager Therapeutics Announces Appointment of Toby Ferguson as Chief Medical Officer - Voyager Therapeutics (NASDAQ:VYGR)

LEXINGTON, Mass., March 13, 2024 (GLOBE NEWSWIRE) -- Voyager Therapeutics, Inc. (NASDAQ:VYGR), a biotechnology company dedicated to advancing neurogenetic medicines, today announced the appointment of Toby Ferguson,

Related Keywords

,Toby Ferguson ,Adam Bero ,Brooke Shenkin ,Alfredw Sandrock Jr ,Trista Morrison ,Neurocrine Biosciences Inc ,University Of Florida ,Shriners Pediatric Research Center ,Voyager Therapeutics Inc ,Exchange Commission ,Head Of Neuromuscular Development Unit ,University Of Florida College Medicine ,Sangamo Therapeutics Inc ,Temple University School Of Medicine ,University Of Pennsylvania ,Chief Medical Officer ,Vice President ,Neuromuscular Development Unit ,Chief Executive Officer ,Medical Director ,Senior Medical Director ,Executive Medical Director ,Neuromuscular Development ,Assistant Professor ,Temple University School ,Florida College ,Astrazeneca Rare Disease ,Novartis Pharma ,Neurocrine Biosciences ,Sangamo Therapeutics ,Voyager Therapeutics ,Private Securities Litigation Reform Act ,Annual Report ,